Apellis Pharmaceuticals Inc - APLS - stock price prediction, stock price target, analyst ratings from 22 analysts

Apellis Pharmaceuticals Inc has a share price target of US$ 35, revenue growth forecast of 6.7%, and profit growth estimate of -6.6% for FY25, based on top 22 analyst calls.